ライフサイエンスコーパス: pill

1 ables", "progestin", and "oral contraceptive pills".

2 inactive negative ion generator plus placebo pill).

3 eas median opioid consumption was 188 mg (38 pills).

4 tive regimens now available as a one per day pill.

5 ngs, ease, and convenience of a daily-dosing pill.

6 the forces experienced by an orally ingested pill.

7 rticipants received placebo as an additional pill.

8 ther donepezil (5 mg) or a placebo (lactose) pill.

9 binations of DAAs and fixed-dose combination pills.

10 rily and increasingly limited by the size of pills.

11 lso reported findings for oral contraceptive pills.

12 fe, effective method for localizing magnetic pills.

13 ial for improved adherence compared to daily pills.

14 getables containing 300 mg nitrate + placebo pills.

15 an access, afford, and tolerate taking daily pills.

16 was in the range between 5.5 and 49microg in pills.

17 acebo (n = 20): FMUD associated with placebo pills.

18 fies lactate as a component of the "exercise pill."

19 of an active component of the birth control pill (17alpha-ethynylestradiol; EE2) that resulted in th

20 r 30 min/d in the early morning plus placebo pill); (2) antidepressant monotherapy (inactive negative

21 I, 1.75-1.84) and those using progestin-only pills, 2.2 (95% CI, 1.99-2.52).

22 cebo pills, low-nitrate vegetables + nitrate pills (300 mg nitrate), or leafy green vegetables contai

23 69% [P = .18]; patch, 50% to 71% [P = .002]; pills, 41% to 65% [P < .001]; condoms, 25% to 45% [P = .

24 ved a 3-month supply of the progestogen-only pill (75 mug desogestrel) plus a rapid access card to a

25 More respondents chose FMT if offered as a pill (90%; P = .002) or if their physician recommended i

26 ys of order-balanced varenicline and placebo pill administration and were scanned under each conditio

27 oximately 17 days of varenicline and placebo pill administration and were scanned, on different days

28 procedures reported counts of unused opioid pills after discharge.

29 0 or 30 hydrocodone/acetaminophen (5/325 mg) pills after surgery.

30 R], 0.6; 95% CI, .4-1.2), oral contraceptive pill (aHR, 0.8; 95% CI, .3-2.1), nor implant (aHR, 0.8;

31 This is the first report of a single-pill, all-oral, interferon-free, ribavirin-free treatmen

32 ld also be combined into a single fixed-dose pill, along with pyridoxine (vitamin B6), that would be

33 The use of combination pills (also called "polypills") containing low doses of

34 virenz in the United States, a once-daily, 3-pill alternative (generic efavirenz, generic lamivudine,

35 egulate attractive forces between a magnetic pill and an external magnet, while visualizing internal

36 n assumptions were less favorable ($1.00 per pill and disutility=0.00384), CAC screening with statin

37 red the most important attribute and a daily pill and longer lasting injection in the arm were the pr

38 statin assumptions were favorable ($0.13 per pill and no quality of life penalty).

39 rent effects of genuine acupuncture, placebo pill and rest control on pain threshold.

40 een introduced in the market both in vitamin pills and in fortified foods.

41 and 262 women randomized to receive placebo pills and patches.

42 atients and non-infected teens who crush the pills and smoke the powder for its psychoactive effects.

43 We formulated DAAs in drug-polymer pills and studied the release kinetics for 1 mo in vitro

44 s (n=11) after oral ingestion of antioxidant pills and were irradiated (10 mGy).

45 ver medication (P = <0.001, mean 20.0 vs 5.2 pills), and were over 3 times more likely to still be ta

46 f pre-exposure prophylaxis is a costly daily pill, and it is recognized that several options will be

47 at could interfere with the progestogen-only pill, and willing to give contact details for follow-up

48 o filled an opioid prescription had leftover pills, and 26 of the 49 patients (53%) planned to keep t

49 Medroxyprogesterone Acetate (DMPA), implant, pills, and intrauterine device (IUD)) were promoted and

50 x, race, numeracy, difficulty with obtaining pills, and number of pills taken per day but did not var

51 n in the control group received multivitamin pills, and the intervention group received vitamins and

52 ts using fixed-combination, low-dose, triple-pill antihypertensive therapy (consisting of amlodipine,

53 variants of an innovator drug have the same pill appearance to reduce errors and promote drug adhere

54 In many cases excess pills are prescribed.

55 pharmacist provision of the progestogen-only pill as a bridging interim method of contraception with

56 olesterol-lowering medications into a single pill associated with improved cardiovascular disease (CV

57 'polypill strategy' refers to making such a pill available to the population based on age (e.g. 55 y

58 otential oral administration of any magnetic pill-based delivery system.

59 ice-daily nevirapine with separate companion pills because of interactions between efavirenz and beda

60 ill devices that transmit data each time the pill bottle is opened.

61 ounced home-based pill counts and electronic pill bottle monitoring.

62 participants' capecitabine bottles to record pill bottle openings.

63 hypertensive medication identified through a pill bottle review.

64 ntly associated with completing 2 or more 28-pill bottles of sofosbuvir-velpatasvir (P < .001) and re

65 er flea), Cladocera (brine shrimp), Isopoda (pill bugs), Amphipoda (scuds, sideswimmers), and Decapod

66 (24%), experiencing side effects (20%), and pill burden (17%).

67 s (HCV) genotype 1, the regimens have a high pill burden and are associated with increased rates and

68 enefit from regimen simplification to reduce pill burden and dosing frequency.

69 Simplified regimens with reduced pill burden and fewer side-effects are desirable for peo

70 ens are simpler than in the past, with lower pill burden and once-daily dosing frequency common.

71 d trials (RCTs) to investigate the impact of pill burden and once-daily vs twice-daily dosing on ART

72 pends more on the disutility associated with pill burden than their degree of cardiovascular risk.

73 Lower pill burden was associated with both better adherence an

74 Higher pill burden was associated with both lower adherence rat

75 e disutility caused by daily medication use (pill burden).

76 ults with consideration of dosing frequency, pill burden, adverse toxic effect profiles, comorbiditie

77 emental toxic effects, high costs, increased pill burden, and many drug interactions.

78 Omitting NRTIs will reduce pill burden, cost, and toxicity in this patient populati

79 tease inhibitor-containing regimens, greater pill burden, higher maximum number of doses per day, and

80 it generally effective, are hampered by high pill burden, long duration of treatment, coexistent toxi

81 reduced dosages was associated with reduced pill burden, reduced treatment costs, and a trend toward

82 Fixed-dose combinations could reduce pill burdens and costs as well as improving patient adhe

83 The proposed method (PILL) can serve as a valuable tool for protein function

84 (4 month assessment) assessed via electronic pill caps (Medication Event Monitoring System [MEMS]) wi

85 ; NuvaRing), and combined oral contraceptive pills (COCPs) on cervical Th17 cells and cytokines were

86 uvaRing(R)), and combined oral contraceptive pills (COCPs) on cervical Th17 cells and cytokines were

87 eligible for TIPS, Poly-Iran, Wald, and the PILL Collaboration, CAC = 0 was observed in 58.6%, 54.5%

88 patients increased by 34% after a change in pill color (adjusted odds ratio, 1.34 [95% CI, 1.12 to 1

89 Rates of changes in pill color and shape during the year after MI were calcu

90 sistence were evaluated to determine whether pill color or shape had changed.

91 The term 'polypill' denotes a single-pill combination of drugs for reducing cardiovascular di

92 s for blood pressure measurement, and single-pill combination pharmacotherapy.

93 more, our model predicts that certain single-pill combination therapies can prevent resistance regard

94 Although initial single-pill combination therapy is strongly recommended in both

95 In comparison with monotherapy, single-pill combinations and multiple-pill combinations were as

96 ady been randomised to treatment with single-pill combinations of either benazepril and hydrochloroth

97 erapy, single-pill combinations and multiple-pill combinations were associated with 55% and 26% incre

98 item-respondents could select birth control pills; condoms; an intrauterine device or implant; injec

99 pplementation with leafy green vegetables or pills containing the same amount of inorganic nitrate do

100 vs 35%; p=0.001) and have adherence <90% by pill count (42 vs. 0%; p=0.02).

101 nding the final visit with MAQ = 20 and high pill count (80% to 110%) combined, to assess adherence.

102 ported Morisky-Green questionnaire (MAQ) and pill count (patients had to meet both criteria for adher

103 y; counseling was intensified if unannounced pill count adherence fell to <80%.

104 was 98.6% (standard deviation [SD], 2.4) by pill count and 98.5% (SD, 2.7) by self-report; 86% repor

105 Compliance was monitored by pill count and change in serum 25(OH)D concentration usi

106 east 20% of doses were missed as measured by pill count and failure to open the medication monitor bo

107 gh adherence to the study medication (92% by pill count).

108 ion adherence was 97% by self-report, 96% by pill count, and 84% by urine monitoring.

109 doses missed or not ingested with a meal, by pill count, and by plasma concentrations of tenofovir an

110 n was 88%, as confirmed by video-calling and pill count, and corroborated by corresponding drug and a

111 ment, 66% a urine drug test (UDT), and 12% a pill count.

112 Among women with complete pill counts (97% adherence), the mean decrease in CRP wa

113 taken) assessed by 2 unannounced home-based pill counts 30 days apart at the 6-month endpoint.

114 rtile range [IQR] 96.9%-100%) by unannounced pill counts and 97.2% (90.6%-100%) by electronic monitor

115 PrEP adherence using unannounced home-based pill counts and electronic pill bottle monitoring.

116 However, while pill counts and self-reports indicated that more than 66

117 296 participants had data for pill counts at week 4 and 8; 271 (92%) had 100% adherenc

118 nd measured using clinical documentation and pill counts for direct observation, and self-reports, pi

119 opioid treatment agreements, 9.5 (6-10) for pill counts, and 10 (8-10) for UDT.

120 ts for direct observation, and self-reports, pill counts, and medication event-monitoring devices for

121 nts, performing urine drug tests, monitoring pill counts, and reviewing prescription drug monitoring

122 etrics of drug adherence (e.g., self-report, pill counts, blood monitoring) have limitations, and ana

123 olypill regimen, as assessed on the basis of pill counts, was 86%.

124 , 1.77-2.15]) than were doses less than 0.75 pills/d (OR, 1.63 [95% CI, 1.48-1.78]; P = .007 for inte

125 Doses more than 1.5 PPI pills/d were more strongly associated with vitamin B12 d

126 er for higher daily doses (>1.5 vs <0.75 PPI pills/d; P value interaction = .004) and decreased after

127 Mean utility for taking a pill daily for cardiovascular prevention is approximatel

128 ensitive to patient preferences for taking a pill daily, changes to statin price, and the risk of sta

129 s in the disutility associated with taking a pill daily, statin price, and the risk of statin-induced

130 to pay an average of $1445 to avoid taking a pill daily, which translated to a mean utility of 0.994

131 amount of time to avoid taking a preventive pill daily.

132 se risk factors if they do not mind taking a pill daily.

133 ong burden and stigma associated with taking pills daily and can experience medication fatigue that m

134 eas over 90% of participants reported taking pills daily while on early ART.

135 ess than a college degree; and 79% took >/=1 pills daily.

136 t UTI prevention compared to daily cranberry pills, daily estrogen therapy, and acupuncture.

137 cts received one of four treatments: placebo pills (described as Tylenol), sham acupuncture, genuine

138 e their medications (70.6%); and that taking pills did not interfere with their daily activities (85.

139 with either bupropion or a matching placebo pill (double-blind).

140 of varenicline (0.5 mg) or matching placebo pill (double-blind, random order) before imaging.

141 t guidelines recommend branded once-daily, 1-pill efavirenz-emtricitabine-tenofovir as first-line ant

142 PILL estimates the missing labels for a protein based on

143 The fraction of time pills experience ranges of forces and torques are analyz

144 Scaled up investment in the triple pill for hypertension management in Sri Lanka should be

145 The decrease in utility attributed to taking pills for cardiovascular prevention can have major effec

146 igh adherence as self-report of taking "all" pills for each prescribed ART medication; all other repo

147 placebo and smaller nocebo effects than did pills for the treatment of hot flashes.

148 y to effectively transfer food, liquids, and pills from their mouth to stomach.

149 and 1 cell/high-power field [hpf] in the no-pill group, 39 ng/L and 1 cell/hpf in the blinded placeb

150 he blinded placebo group; and 286 for the no-pill group.

151 The pill groups had more treatment-related adverse events th

152 Users of progestogen-only pills had an RR for first use of an antidepressant of 1.

153 ly more opioid (P = <0.001, mean 11.9 vs 6.4 pills), had significantly more leftover medication (P =

154 ctions using Incomplete hierarchical LabeLs (PILL in short).

155 o measurements of the movement of a magnetic pill in the stomachs of fasted and fed humans.

156 rofile, parity and use of oral contraceptive pills in females, smoking and alcohol intake in males di

157 se outcomes, including diversion of leftover pills in the community and rising rates of opioid use di

158 DAAs was enabled for 1 mo with drug-polymer pills in vitro, and the LA-DAAS safely and successfully

159 rate (TDF) and emtricitabine (FTC), the quad pill includes cobicistat (COBI; an inactivator of cytoch

160 adults 65 years of age or older, choking or pill-induced dysphagia or globus caused 37.6% (95% CI, 2

161 entified articles, recording treatment type (pill, injection, or other) and whether placebo compositi

162 lowing as modern contraceptive methods: oral pills, intrauterine devices, injectables, male and femal

163 The Matlab code of PILL is available upon request.

164 rologic and immunologic efficacy of the quad pill is equivalent to that of other comparator regimens

165 PILL is shown to outperform other related techniques in

166 The quad pill is the newest single-pill, once-daily option for th

167 Variation in the appearance of generic pills is associated with nonpersistent use of these esse

168 ien) is the most widely prescribed "sleeping pill." It makes the inhibitory neurotransmitter GABA wor

169 What our magnetic pill localization strategy adds to the state of the art,

170 y for 5 wk: low-nitrate vegetables + placebo pills, low-nitrate vegetables + nitrate pills (300 mg ni

171 combined oestrogen-progestagen contraceptive pill might decrease lamotrigine concentrations, which co

172 states subsequently implemented mandates and pill mill laws.

173 of medicines for dyspepsia (from 3.7 to 2.4 pills/month) and painkillers (6.8-5.5 pills/month) and t

174 to 2.4 pills/month) and painkillers (6.8-5.5 pills/month) and the number of antibiotic courses (0.6-0

175 device (LNG-IUD; n = 27), oral contraceptive pills (n = 32), or no hormonal contraception (n = 33).

176 Patients initially prescribed 30 pills (n = 79), when compared with patients initially pr

177 mpared with patients initially prescribed 10 pills (n = 95), used significantly more opioid (P = <0.0

178 ore sex and one dose within 24 h after sex), pills needed or used to achieve regimen-specific adheren

179 We included 21 nonoral contraceptive pill (non-OCP) users who self-collected vaginal samples

180 such that all volunteers received identical pill numbers.

181 ng a combined, monophasic oral contraceptive pill (OCP) (>=12 months) during exercise in dry and humi

182 ed after cessation of the oral contraceptive pill (OCP) and associated adenoma regression.

183 ons between sex hormones, oral contraceptive pill (OCP) use, systemic inflammation and airway inflamm

184 ke a combined, monophasic oral contraceptive pill (OCP).

185 To evaluate the effect of oral contraceptive pills (OCP) on the macula, the retinal nerve fiber layer

186 uptake among women using oral contraception pills (OCPs) compared to women using injectable or long-

187 Oral contraceptive pills (OCPs) have been associated with improvement for m

188 associated with using pyridostigmine bromide pills [odds ratio (OR) = 3.5; 95% confidence interval (C

189 2, participants were randomized to take one pill of THC or placebo (PBO) 2-h before threat extinctio

190 Participants took a median of 15 pills of TDF-FTC or placebo per month (P=0.57).

191 ability to monitor the force exerted by the pill on the tissue and to locate the magnetic pill withi

192 The quad pill is the newest single-pill, once-daily option for the treatment of human immun

193 lity of the combination of simeprevir, a one-pill, once-daily, oral HCV NS3/4A protease inhibitor ver

194 fety of the combination of simeprevir, a one pill, once-daily, oral HCV NS3/4A protease inhibitor, pl

195 treat all only if statin cost exceeded $3.16/pill or if testing increased adherence from <22% to >75%

196 -associated factors (intake of birth control pills or estrogens and number of births) were not associ

197 the median consumption was 3 5 mg oxycodone pills or less.

198 re' placebos are interventions such as sugar pills or saline injections without direct pharmacologica

199 urred when the oral contraceptive pill ("the Pill" or "OCP") was approved.

200 the effects of exercise, so-called 'exercise pills' or 'exercise mimetics.' These compounds have, to

201 ), nicotine patch (active patch plus placebo pill), or varenicline (active pill plus placebo patch),

202 otein powder, soy protein powder and placebo pill, or venlafaxine and soy protein powder.

203 ception is superior to that of contraceptive pills, patch, or ring and is not altered in adolescents

204 eptive failure rate among participants using pills, patch, or ring was 4.55 per 100 participant-years

205 Among participants who used pills, patch, or ring, those who were less than 21 years

206 PAa, placebo acupuncture; placebo cetirizine pill, PC) and a no-intervention control (NI).

207 associations were among persons taking >1.5 pills per day for at least 10 years (odds ratio, 4.27; 9

208 performance on loss to follow-up and on-time pill pickup were explored, and appropriate corrective ac

209 Is but missed the desired target for on-time pill pickup, pharmacy stockouts, and virological suppres

210 Targets were missed for on-time pill pickup, retention in care, and virological suppress

211 s for rates of loss to follow-up and on-time pill pickup.

212 to -0.11), and SSRIs and SNRIs compared with pill placebo (-0.44, -0.67 to -0.22) were the only class

213 sure therapy and were randomly assigned to a pill placebo (n = 14) or 50 mg of DCS (n = 15) immediate

214 specific pharmacological effect relative to pill placebo for patients with less severe depression.

215 rapy was associated with fewer dropouts than pill placebo or medications.

216 avioral therapy, medication, combination, or pill placebo) in the Child/Adolescent Anxiety Multimodal

217 cessation with commonly used treatments (and pill placebo) lead to decreased alpha4beta2* nAChR densi

218 0 mg/d), (2) prolonged exposure therapy plus pill placebo, (3) supportive counseling plus naltrexone

219 ong with the effect of low-dose varenicline, pill placebo, and smoking-to-satiety on withdrawal ratin

220 Compared with pill placebo, selective serotonin reuptake inhibitors (S

221 nitive-behavioral therapy, bupropion HCl, or pill placebo.

222 to SRIs was superior to both risperidone and pill placebo.

223 100 mg/d), or (4) supportive counseling plus pill placebo.

224 /RP (17 sessions delivered twice weekly), or pill placebo.

225 talopram; escitalopram plus CBT, followed by pill placebo; and escitalopram alone, followed by placeb

226 :1:1 ratio), to 11 weeks of placebo (placebo pill plus placebo patch), nicotine patch (active patch p

227 h plus placebo pill), or varenicline (active pill plus placebo patch), plus behavioural counselling.

228 IV risk in ten studies of oral contraceptive pills (pooled HR 1.00, 0.86-1.16) or five studies of nor

229 o controls (sham acupuncture [SA] or placebo pills [PPs]).

230 e recommendations would result in 47%-56% of pills prescribed remaining unused.

231 was a wide variation in the number of opioid pills prescribed to patients undergoing the same operati

232 ian Polycap Study], Poly-Iran, Wald, and the PILL [Program to Improve Life and Longevity] Collaborati

233 equivalents (MME) dispensed, and quantity of pills (QTY) dispensed.

234 Yet, safe, effective pill retention within a desired region of the GI remains

235 ents with Lewy body disease; resting tremor, pill-rolling tremor and hallucinations were more frequen

236 costs (for repeat prescription), followed by pills running out, not wanting others to notice, side-ef

237 forward in the ability to localize magnetic pills safely and effectively anywhere within the GI trac

238 though prescription drugs (prescription pain pills, sedatives, and tranquilliser) were the most commo

239 s no significant association between placebo pills, sham acupuncture and cue conditioning effects, in

240 CI, 1.12 to 1.59]) and 66% after a change in pill shape (adjusted odds ratio, 1.66 [CI, 1.43 to 1.94]

241 of patients (3286 of 11,513) had a change in pill shape or color during the study.

242 that assessed the use of oral contraceptive pills showed no significant association with HIV acquisi

243 These contaminants are like gluten 'pills', shown here to skew gluten analysis results.

244 Barriers to PrEP included taking a daily pill, side-effects, and cost.

245 tend that an underappreciated consequence of pill size is unequal dosing in comparative clinical tria

246 nally, given that some calls for an exercise pill stem from a response to the perceived failure of ex

247 Compared with usual care, the triple-pill strategy is cost-effective for patients with mild-t

248 The triple-pill strategy, compared with usual care, cost an additio

249 assess the cost-effectiveness of the triple-pill strategy.

250 ice that can be ingested as a standard-sized pill, swell rapidly into a large soft sphere, and mainta

251 vitamin D3 or an identically matched placebo pill taken orally every other week starting at 3 mo afte

252 sult of more fully covered sex acts and more pills taken around partially covered acts.

253 sult of more fully covered sex acts and more pills taken around partially covered acts.

254 The regimen comprised 3 pills taken daily.

255 fficulty with obtaining pills, and number of pills taken per day but did not vary by education level,

256 conducted to determine the number of opioid pills taken.

257 PILL takes into account the hierarchical and the flat ta

258 HPTN) 067/Alternative Dosing to Augment PrEP Pill Taking (ADAPT) Study evaluated the feasibility of d

259 ered monthly, circumvents the need for daily pill taking, potentially improving adherence, and has be

260 We sought to measure the utility of daily pill-taking for cardiovascular prevention.

261 Disclosure was less common for pills than for injections and other treatments (8.2% vs.

262 es swallowing an optomechanically engineered pill that captures cross-sectional microscopic images of

263 nsider the complex challenges of designing a pill that might mimic the extensive range of exercise be

264 t proportion of elderly people from taking a pill that would benefit only a few.

265 owledge could help in the design of sleeping pills that induce a more natural sleep.

266 obtained refills.We identified the number of pills that would fully supply the opioid needs of 80% of

267 hows that it might be possible to develop a 'pill' that awakens the innate immune system to kill canc

268 debate occurred when the oral contraceptive pill ("the Pill" or "OCP") was approved.

269 e form for the goal of "carbon monoxide in a pill." This should enable non-inhalation administration

270 The median velocity of the magnetic pill through the small intestine in the fasting state wa

271 her, was the median velocity of the magnetic pill through the small intestine in the postprandial sta

272 e-blinded randomized trial comparing placebo pill to duloxetine.

273 rocedures and to estimate an ideal number of pills to prescribe.

274 advance from traditional oral contraceptive pills, to improve upon safety, efficiency, and complianc

275 ed contraceptive methods (oral contraceptive pills, transdermal patch, contraceptive vaginal ring, an

276 1 (n = 17) was a 2-wk single-blinded placebo pill trial.

277 of 20 mg of doxycycline or matching placebo pill twice a day at least 2 days prior to surgery, on th

278 in the TDF-FTC group had evidence of recent pill use at visits that were matched to the HIV-infectio

279 iabetes mellitus, cancer, oral contraceptive pill use, surgical menopause, hormone replacement therap

280 ales were not matched for oral contraceptive pill use.

281 t be explained by differential contraceptive pill use.

282 molecules varied between oral contraceptive pill users, postmenopausal females, and females in the f

283 This approach was exemplified on QiShenYiQi Pills using thrombin and angiotensin converting enzyme a

284 or 12 weeks: milk protein powder and placebo pill, venlafaxine and milk protein powder, soy protein p

285 that different types of placebos (e.g. inert pill versus sham device) may yield different magnitudes

286 The Triple Pill versus Usual Care Management for Patients with Mild

287 osage, supply days, and numbers of dispensed pills was extracted from the Taiwan National Health Insu

288 enicline and twice while receiving a placebo pill, wearing either a nicotine or a placebo patch.

289 d core temperature via ingestible telemetric pill were measured continuously; cutaneous vascular cond

290 Fewer pills were needed for complete adherence in women alloca

291 Only 28% of the prescribed pills were taken.

292 alent to one hundred twenty 5-mg hydrocodone pills), whereas median opioid consumption was 188 mg (38

293 users face barriers to adherence using daily pills, which could be reduced by long-acting formulation

294 randomly assigned (1:1) to receive either a pill with active pre-exposure prophylaxis or placebo, ta

295 rovision of a supply of the progestogen-only pill with emergency contraception from a community pharm

296 t was change in the velocity of the magnetic pill within the small intestine.

297 ill on the tissue and to locate the magnetic pill within the test subject all in real time.

298 ndent of the distribution of the capsules or pills within the RF coil and is therefore more suitable

299 e authentication can verify every individual pill without removing the identification tag.

300 jury when they are treated with the sleeping pill zolpidem.